IBDEI0NQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11078,1,4,0)
 ;;=4^H81.93
 ;;^UTILITY(U,$J,358.3,11078,2)
 ;;=^5006889
 ;;^UTILITY(U,$J,358.3,11079,0)
 ;;=R63.0^^47^527^1
 ;;^UTILITY(U,$J,358.3,11079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11079,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,11079,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,11079,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,11080,0)
 ;;=R64.^^47^527^2
 ;;^UTILITY(U,$J,358.3,11080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11080,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,11080,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,11080,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,11081,0)
 ;;=E86.0^^47^527^4
 ;;^UTILITY(U,$J,358.3,11081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11081,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,11081,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,11081,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,11082,0)
 ;;=Z86.31^^47^527^75
 ;;^UTILITY(U,$J,358.3,11082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11082,1,3,0)
 ;;=3^Personal Hx of Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,11082,1,4,0)
 ;;=4^Z86.31
 ;;^UTILITY(U,$J,358.3,11082,2)
 ;;=^5063467
 ;;^UTILITY(U,$J,358.3,11083,0)
 ;;=E10.8^^47^527^5
 ;;^UTILITY(U,$J,358.3,11083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11083,1,3,0)
 ;;=3^Diabetes Type 1 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,11083,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,11083,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,11084,0)
 ;;=E10.9^^47^527^6
 ;;^UTILITY(U,$J,358.3,11084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11084,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,11084,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,11084,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,11085,0)
 ;;=E11.40^^47^527^15
 ;;^UTILITY(U,$J,358.3,11085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11085,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,11085,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,11085,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,11086,0)
 ;;=E11.620^^47^527^11
 ;;^UTILITY(U,$J,358.3,11086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11086,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Dermatitis
 ;;^UTILITY(U,$J,358.3,11086,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,11086,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,11087,0)
 ;;=E11.610^^47^527^14
 ;;^UTILITY(U,$J,358.3,11087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11087,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,11087,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,11087,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,11088,0)
 ;;=E11.52^^47^527^17
 ;;^UTILITY(U,$J,358.3,11088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11088,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,11088,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,11088,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,11089,0)
 ;;=E11.51^^47^527^18
 ;;^UTILITY(U,$J,358.3,11089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11089,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,11089,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,11089,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,11090,0)
 ;;=E11.621^^47^527^21
 ;;^UTILITY(U,$J,358.3,11090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11090,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,11090,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,11090,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,11091,0)
 ;;=E11.44^^47^527^8
 ;;^UTILITY(U,$J,358.3,11091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11091,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Amyotrophy
